WCM
CELG

Windsor Capital Management’s Celgene Corp CELG Stock Holding History

Windsor Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-226
Closed -$17K – 433
2013
Q3 		$17K Hold
226
– – 0.01% 297
2013
Q2 		$13K Buy
+226
New +$13.6K 0.01% 309

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Windsor Capital Management's CELG Position: Q4 2013 in Review

Windsor Capital Management sold out of Celgene Corp (CELG) in Q4 2013, closing a stake of 226 shares — an estimated $17K sold.

Windsor Capital Management first reported a position in CELG in Q2 2013 and held it in 2 quarters. The position peaked at $17K in Q3 2013. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • Windsor Capital Management reported no remaining Celgene Corp position as of Q4 2013 after selling out during the quarter.
  • Windsor Capital Management sold 226 Celgene Corp shares in Q4 2013, an estimated $17K.
  • Windsor Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 2 quarters.
  • Windsor Capital Management's Celgene Corp position peaked at $17K in Q3 2013.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on Windsor Capital Management's 13F filing for Q4 2013, filed 10 Jan 2014.